Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

velixX Video

velixX: The Next Generation System Development Company

1 December 2017

Full company details

APIs

Vaccine development: the need for speed

Lack of CMO availability threatens cell and gene therapy development

Novaliq’s NovaTears+Omega-3 represents the first-in-class omega-3-containing eye drop for evaporative dry eye

Approvals

FDA approves Opdivo/Yervoy combo treatment for kidney cancer

FDA grants fast track designation to Proteostasis CF therapy

Sanofi seeks EMA approval for asthma drug Dupixent

Clinical Research

Low-cost anti-hookworm treatment found to be effective

AACR 2018: revisiting murine models to develop drug combos for KRAS-driven cancers

AACR 2018: SLFN11 predicts response to PARP inhibition in small cell lung cancer

Clinical Trials

AACR 2018: SLFN11 predicts response to PARP inhibition in small cell lung cancer

TaiwanJ’s JKB-121 falls victim to unexpected placebo response in NASH patients

ILC 2018: NGM’s intravenous NASH therapy shows rapid reduction in liver fat content and fibrosis

Diseases

Low-cost anti-hookworm treatment found to be effective

AACR 2018: revisiting murine models to develop drug combos for KRAS-driven cancers

AACR 2018: SLFN11 predicts response to PARP inhibition in small cell lung cancer

Genomics & Proteomics

AACR 2018: revisiting murine models to develop drug combos for KRAS-driven cancers

Lack of CMO availability threatens cell and gene therapy development

The age of immortality

Market Data

CD40 agonist developments could support Anti-PD-(L)1 therapy in pancreatic cancer

ILC 2018: Madrigal Therapeutics’ MCL-3196 reduces liver fat in NASH patients

ILC 2018: Allergan’s cenicriviroc shows continued fibrosis response in NASH patients in two year extended study

Technology

Algorithm optimises peptides to target drug-resistant bacteria

Computer simulation offers digital penicillin production

Synthetic circuits and feedback loops enable bacteria to produce drugs

velixX Video

velixX: The Next Generation System Development Company

Make an enquiry

Drug Development Technology is using cookies

Make an enquiry

More about this company

Follow this company to receive notifications when they update